annual CAPEX:
$17.05M+$4.49M(+35.80%)Summary
- As of today (July 4, 2025), RXRX annual capital expenditures is $17.05 million, with the most recent change of +$4.49 million (+35.80%) on December 31, 2024.
- During the last 3 years, RXRX annual CAPEX has fallen by -$22.75 million (-57.17%).
- RXRX annual CAPEX is now -57.17% below its all-time high of $39.80 million, reached on December 31, 2021.
Performance
RXRX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$1.83M+$184.00K(+11.17%)Summary
- As of today (July 4, 2025), RXRX quarterly capital expenditures is $1.83 million, with the most recent change of +$184.00 thousand (+11.17%) on March 31, 2025.
- Over the past year, RXRX quarterly CAPEX has dropped by -$4.82 million (-72.46%).
- RXRX quarterly CAPEX is now -90.56% below its all-time high of $19.42 million, reached on March 31, 2021.
Performance
RXRX quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$12.22M-$4.82M(-28.28%)Summary
- As of today (July 4, 2025), RXRX TTM capital expenditures is $12.22 million, with the most recent change of -$4.82 million (-28.28%) on March 31, 2025.
- Over the past year, RXRX TTM CAPEX has dropped by -$1.64 million (-11.84%).
- RXRX TTM CAPEX is now -69.38% below its all-time high of $39.92 million, reached on September 30, 2021.
Performance
RXRX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
RXRX CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +35.8% | -72.5% | -11.8% |
3 y3 years | -57.2% | -57.8% | -50.6% |
5 y5 years | +335.9% | - | - |
RXRX CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -57.2% | +35.8% | -88.9% | +121.5% | -68.1% | at low |
5 y | 5-year | -57.2% | +335.9% | -90.6% | +121.8% | -69.4% | +1379.9% |
alltime | all time | -57.2% | +335.9% | -90.6% | +121.8% | -69.4% | +1379.9% |
RXRX CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $1.83M(+11.2%) | $12.22M(-28.3%) |
Dec 2024 | $17.05M(+35.8%) | $1.65M(-63.9%) | $17.05M(-4.3%) |
Sep 2024 | - | $4.56M(+9.1%) | $17.81M(+26.5%) |
Jun 2024 | - | $4.18M(-37.1%) | $14.08M(+1.5%) |
Mar 2024 | - | $6.65M(+175.3%) | $13.87M(+10.5%) |
Dec 2023 | $12.55M(-66.4%) | $2.42M(+192.3%) | $12.55M(-30.7%) |
Sep 2023 | - | $827.00K(-79.2%) | $18.11M(-29.9%) |
Jun 2023 | - | $3.97M(-25.7%) | $25.85M(-32.6%) |
Mar 2023 | - | $5.34M(-33.1%) | $38.36M(+2.7%) |
Dec 2022 | $37.36M | $7.98M(-6.8%) | $37.36M(+10.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2022 | - | $8.56M(-48.0%) | $33.84M(-3.3%) |
Jun 2022 | - | $16.48M(+279.4%) | $34.99M(+41.5%) |
Mar 2022 | - | $4.34M(-2.7%) | $24.72M(-37.9%) |
Dec 2021 | $39.80M(+490.9%) | $4.46M(-54.0%) | $39.80M(-0.3%) |
Sep 2021 | - | $9.71M(+56.2%) | $39.92M(+28.6%) |
Jun 2021 | - | $6.21M(-68.0%) | $31.05M(+25.0%) |
Mar 2021 | - | $19.42M(+322.9%) | $24.83M(+358.4%) |
Dec 2020 | $6.74M(+72.3%) | - | - |
Dec 2020 | - | $4.59M(+455.8%) | $5.42M(+555.8%) |
Sep 2020 | - | $826.00K | $826.00K |
Dec 2019 | $3.91M | - | - |
FAQ
- What is Recursion Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual CAPEX year-on-year change?
- What is Recursion Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Recursion Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals TTM CAPEX year-on-year change?
What is Recursion Pharmaceuticals annual capital expenditures?
The current annual CAPEX of RXRX is $17.05M
What is the all time high annual CAPEX for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual capital expenditures is $39.80M
What is Recursion Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, RXRX annual capital expenditures has changed by +$4.49M (+35.80%)
What is Recursion Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of RXRX is $1.83M
What is the all time high quarterly CAPEX for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly capital expenditures is $19.42M
What is Recursion Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, RXRX quarterly capital expenditures has changed by -$4.82M (-72.46%)
What is Recursion Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of RXRX is $12.22M
What is the all time high TTM CAPEX for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high TTM capital expenditures is $39.92M
What is Recursion Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, RXRX TTM capital expenditures has changed by -$1.64M (-11.84%)